It has been proposed that such compensatory activity may initially counterbalance emerging metabolic dysregulation, but may become impaired over time, particularly with the progression of obesity and the onset of leptin resistance, further exacerbating both metabolic and affective disturbances, as shown in a study in mice [77]. This evidence concerns the gene LEP and obesity disorder.